Related Experiment Video
Updated: Jun 1, 2026

10:33
Efficient Purification and LC-MS/MS-based Assay Development for Ten-Eleven Translocation-2 5-Methylcytosine Dioxygenase
Published on: October 15, 2018
N,3'-cyclo-5'-O-Cyano-methyl-thymidine
Jingbo Sun1, Kun Yang, Ronghui Duan
1College of Chemistry, Jilin University, Changchun 130012, People's Republic of China.
Summary
This study details a novel cyclo-nucleoside with a C-N linkage. Structural analysis reveals its specific furan-ose ring conformation and hydrogen bonding patterns, important for understanding nucleoside analogs.
Area of Science:
- Medicinal Chemistry
- Structural Biology
- Crystallography
Background:
- Cyclo-nucleosides are important pharmaceutical compounds.
- Understanding their structure is key to drug design.
Purpose of the Study:
- To characterize the structure of a novel cyclo-nucleoside.
- To analyze its conformation and intermolecular interactions.
Main Methods:
- X-ray crystallography was used to determine the molecular structure.
- Conformational analysis of the furan-ose ring was performed.
Main Results:
- The compound is a cyclo-nucleoside with a C-N linkage (C19H20N4O4).
- The furan-ose ring adopted a twist C3'-endo/C2'-exo conformation (P=8.1°, vm=30.6°).
- The pyrimidine ring was in an anti orientation, with intra-molecular and inter-molecular hydrogen bonds observed.
Conclusions:
- The determined structure provides a basis for understanding the properties of this cyclo-nucleoside.
- The observed conformation and hydrogen bonding are critical for its potential biological activity.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...

